BAP1 is overexpressed in Black compared with White patients with Mx-M1 Clear Cell Renal Cell Carcinoma.
BAP1 overexpression is associated with decreasing pathologic stage.
This may explain why more tumors are localized in Black vs. White patients.
BAP1 overexpression portends distinct pathologic outcomes in Black and White patients.
Racial stratification is needed in BAP1 biomarker studies.